Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder characterized by progressive and variable involvement of tissues predominantly derived from the neural crest and a predisposition toward malignancies. The NF1 gene encodes neurofibromin, a GTPase–activating protein containing a GAP–related domain (NF1–GRD) that is capable of down–regulating ras by stimulating its intrinsic GTPase activity. We report a homozygous deletion of most of NF1 in one of eight malignant melanoma cell lines leading to loss of detectable mRNA and protein, as well as the apparent absence of protein and mRNA in another melanoma. This data suggests that NF1 can function as a tumour suppressor gene in the development or progression of malignant melanoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Martuza, R.L. et al. Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. J. Invest. Derm. 85, 347–50 (1985).

    Article  CAS  Google Scholar 

  2. Riccardi, V.M. & Eichner, J.E. Neurofibromatosis: Phenotype, Natural History and Pathogenesis (John Hopkins, Baltimore, 1986).

    Google Scholar 

  3. Bolande, R.P. Neurofibromatosis - the quintessential neurocristopathy: pathogenetic concepts and relationships. Adv. Neurol. 29, 67–75 (1981).

    CAS  PubMed  Google Scholar 

  4. Wallace, M.R. et al. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249, 181–189 (1990).

    Article  CAS  Google Scholar 

  5. Gutmann, D.H., Wood, D.L. & Collins, F.S. Identification of the neurofibromatosis type 1 gene product. Proc. natn. Acad. Sci. U.S.A. 88, 9658–9662 (1991).

    Article  CAS  Google Scholar 

  6. DeClue, J.E., Cohen, B.D. & Lowy, D.R. Identification and characterization of the neurofibromatosis type 1 protein product. Proc. natn. Acad. Sci. U.S.A. 88, 9914–9918 (1991).

    Article  CAS  Google Scholar 

  7. Daston, M.M. et al. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8, 415–28 (1992).

    Article  CAS  Google Scholar 

  8. Xu, G. et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599–608 (1990).

    Article  CAS  Google Scholar 

  9. Ballester, R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851–559 (1990).

    Article  CAS  Google Scholar 

  10. Martin, G.A. et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843–849 (1990).

    Article  CAS  Google Scholar 

  11. Viskochil, D. et al. Deletions and atranslocation breakpoint interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187–192 (1990).

    Article  CAS  Google Scholar 

  12. Upadhyaya, M. et al. A 90 kb DNA deletion associated with neurofibromatosis type 1. J. med. Genet. 27, 738–741 (1990).

    Article  CAS  Google Scholar 

  13. Cawthon, R.M. et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, gene structure, and point mutations. Cell 62, 193–201 (1990).

    Article  CAS  Google Scholar 

  14. Wallace, M.R. et al. A de novo Alu insertion results in neurofibromatosis type 1. Nature 353, 864–866 (1991).

    Article  CAS  Google Scholar 

  15. Li, Y. et al. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69, 275–281 (1992).

    Article  CAS  Google Scholar 

  16. Herlyn, M. et al. Biology of tumor progression in human melanocytes. Lab Invest 56, 461–474 (1987).

    CAS  PubMed  Google Scholar 

  17. Dracopoli, N.C., Houghton, A.N. & Old, L.J. Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity. Proc. natn. Acad. Sci. U.S.A. 82, 1470–1474 (1985).

    Article  CAS  Google Scholar 

  18. Dracopoli, N.C., Alhadeff, B., Houghton, A.N. & Old, L.J. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res. 47, 3995–4000 (1987).

    CAS  PubMed  Google Scholar 

  19. Fountain, J.W. et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. natn. Acad. Sci. U.S.A. 89, 10557–10561 (1992).

    Article  CAS  Google Scholar 

  20. Dracopoli, N.C. et al. Loss of alleles from distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. natn. Acad. Sci. U.S.A. 86, 4614–4618 (1989).

    Article  CAS  Google Scholar 

  21. Millikin, D., Meese, E., Vogelstein, B., Witkowski, C. & Trent, J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51, 5449–5453 (1991).

    CAS  Google Scholar 

  22. Bean, M.A. et al. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res. 35, 2902–2913 (1975).

    CAS  PubMed  Google Scholar 

  23. Carey, T.E., Takahashi, T., Resnick, L.A., Oettgen, H.F. & Old, L.J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. J. Proc. natn. Acad. Sci. U.S.A. 73, 3278–3282 (1976).

    Article  CAS  Google Scholar 

  24. Fogh, J., Fogh, J.M. & Orfeo, T.J. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. natn. Cancer Inst. 59, 221–226 (1977).

    Article  CAS  Google Scholar 

  25. Albino, A.P., Le Strange, R., Oliff, A.I., Furth, M.E. & Old, L.J. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature 308, 69–72 (1984).

    Article  CAS  Google Scholar 

  26. Marchuk, D.A. et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene. Genomics 11, 931–940 (1991).

    Article  CAS  Google Scholar 

  27. Wallace, M.R., Fountain, J.W., Brereton, A.M. & Collins, F.S. Direct construction of a chromosome-specific Notl linking library from flow-sorted chromosomes. Nucl. Acids Res. 4, 1665–1677 (1989).

    Article  Google Scholar 

  28. White, R. et al. Tightly linked markers for the neurofibromatosis type 1 gene. Genomics 1, 364–67 (1987).

    Article  CAS  Google Scholar 

  29. Sardet, C., Franchi, A. & Pouysségur, J. Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter. Cell 56, 271–280 (1989).

    Article  CAS  Google Scholar 

  30. Becher, R., Gibas, Z., Karakousis, C. & Sandberg, A.A. Nonrandom chromosome changes in malignant melanoma. Cancer Res. 43, 5010–5016 (1983).

    CAS  PubMed  Google Scholar 

  31. Friend, S.H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646 (1986).

    Article  CAS  Google Scholar 

  32. Call, K.M. et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60, 509–520 (1990).

    Article  CAS  Google Scholar 

  33. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).

    Article  CAS  Google Scholar 

  34. Albino, A.P. et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 4, 1363–1374 (1989).

    CAS  PubMed  Google Scholar 

  35. Crowe, F.W., Schull, W.T. & Neel, J.F. Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis (Charles C. Thomas, Springfield, Illinois, 1956).

    Google Scholar 

  36. T'Ang, A., Varley, J.M., Chakraborty, S., Murphree, A.L. & Fung, Y.K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242, 263–266 (1988).

    Article  CAS  Google Scholar 

  37. Sambrook, J., Fritsch, E.F. & Maniatis, T. in Molecular Cloning. A Laboratory Manual 2nd ed. (Cold Spring Harbor Press, New York, 1989).

    Google Scholar 

  38. Harlow, E. & Lane, D. Antibodies: A Laboratory Manual, 421–470 (Cold Spring Harbor Press, New York, 1988).

    Google Scholar 

  39. Basu, T.N. et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713–715 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersen, L., Fountain, J., Gutmann, D. et al. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 3, 118–121 (1993). https://doi.org/10.1038/ng0293-118

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0293-118

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing